FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021743770> ?p ?o ?g. }

• W3021743770 endingPage "1367" @default.
• W3021743770 startingPage "1355" @default.
• W3021743770 abstract "Abstract Aims/hypothesis Inflammatory signals and increased prostaglandin synthesis play a role during the development of diabetes. The prostaglandin D 2 (PGD 2 ) receptor, GPR44/DP2, is highly expressed in human islets and activation of the pathway results in impaired insulin secretion. The role of GPR44 activation on islet function and survival rate during chronic hyperglycaemic conditions is not known. In this study, we investigate GPR44 inhibition by using a selective GPR44 antagonist (AZ8154) in human islets both in vitro and in vivo in diabetic mice transplanted with human islets. Methods Human islets were exposed to PGD 2 or proinflammatory cytokines in vitro to investigate the effect of GPR44 inhibition on islet survival rate. In addition, the molecular mechanisms of GPR44 inhibition were investigated in human islets exposed to high concentrations of glucose (HG) and to IL-1β. For the in vivo part of the study, human islets were transplanted under the kidney capsule of immunodeficient diabetic mice and treated with 6, 60 or 100 mg/kg per day of a GPR44 antagonist starting from the transplantation day until day 4 (short-term study) or day 17 (long-term study) post transplantation. IVGTT was performed on mice at day 10 and day 15 post transplantation. After termination of the study, metabolic variables, circulating human proinflammatory cytokines, and hepatocyte growth factor (HGF) were analysed in the grafted human islets. Results PGD 2 or proinflammatory cytokines induced apoptosis in human islets whereas GPR44 inhibition reversed this effect. GPR44 inhibition antagonised the reduction in glucose-stimulated insulin secretion induced by HG and IL-1β in human islets. This was accompanied by activation of the Akt–glycogen synthase kinase 3β signalling pathway together with phosphorylation and inactivation of forkhead box O-1and upregulation of pancreatic and duodenal homeobox-1 and HGF. Administration of the GPR44 antagonist for up to 17 days to diabetic mice transplanted with a marginal number of human islets resulted in reduced fasting blood glucose and lower glucose excursions during IVGTT. Improved glucose regulation was supported by increased human C-peptide levels compared with the vehicle group at day 4 and throughout the treatment period. GPR44 inhibition reduced plasma levels of TNF-α and growth-regulated oncogene-α/chemokine (C-X-C motif) ligand 1 and increased the levels of HGF in human islets. Conclusions/interpretation Inhibition of GPR44 in human islets has the potential to improve islet function and survival rate under inflammatory and hyperglycaemic stress. This may have implications for better survival rate of islets following transplantation." @default.
• W3021743770 created "2020-05-13" @default.
• W3021743770 creator A5002506738 @default.
• W3021743770 creator A5014684613 @default.
• W3021743770 creator A5015310872 @default.
• W3021743770 creator A5016042114 @default.
• W3021743770 creator A5019973671 @default.
• W3021743770 creator A5055673489 @default.
• W3021743770 creator A5057733587 @default.
• W3021743770 creator A5060621476 @default.
• W3021743770 creator A5083682224 @default.
• W3021743770 creator A5084231801 @default.
• W3021743770 creator A5085138102 @default.
• W3021743770 creator A5086842971 @default.
• W3021743770 date "2020-04-29" @default.
• W3021743770 modified "2023-09-27" @default.
• W3021743770 title "Inhibition of the prostaglandin D2–GPR44/DP2 axis improves human islet survival and function" @default.
• W3021743770 cites W1516009098 @default.
• W3021743770 cites W1570190951 @default.
• W3021743770 cites W1828934168 @default.
• W3021743770 cites W1948540732 @default.
• W3021743770 cites W1966977991 @default.
• W3021743770 cites W1976728837 @default.
• W3021743770 cites W1981676526 @default.
• W3021743770 cites W1991179596 @default.
• W3021743770 cites W2011007681 @default.
• W3021743770 cites W2028187577 @default.
• W3021743770 cites W2028952753 @default.
• W3021743770 cites W2030571587 @default.
• W3021743770 cites W2037620510 @default.
• W3021743770 cites W2041562407 @default.
• W3021743770 cites W2044180737 @default.
• W3021743770 cites W2053669889 @default.
• W3021743770 cites W2064417575 @default.
• W3021743770 cites W2065543070 @default.
• W3021743770 cites W2072185334 @default.
• W3021743770 cites W2075481792 @default.
• W3021743770 cites W2077737366 @default.
• W3021743770 cites W2080199955 @default.
• W3021743770 cites W2081502711 @default.
• W3021743770 cites W2106566135 @default.
• W3021743770 cites W2112115574 @default.
• W3021743770 cites W2116230803 @default.
• W3021743770 cites W2117037434 @default.
• W3021743770 cites W2128442314 @default.
• W3021743770 cites W2134290251 @default.
• W3021743770 cites W2136127635 @default.
• W3021743770 cites W2146228063 @default.
• W3021743770 cites W2153745698 @default.
• W3021743770 cites W2153842599 @default.
• W3021743770 cites W2167900134 @default.
• W3021743770 cites W2234095594 @default.
• W3021743770 cites W2510774880 @default.
• W3021743770 cites W2580495120 @default.
• W3021743770 cites W2581716463 @default.
• W3021743770 cites W2610485306 @default.
• W3021743770 cites W2771116678 @default.
• W3021743770 cites W2905293944 @default.
• W3021743770 cites W4213464763 @default.
• W3021743770 cites W4236706926 @default.
• W3021743770 doi "https://doi.org/10.1007/s00125-020-05138-z" @default.
• W3021743770 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7286861" @default.
• W3021743770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32350565" @default.
• W3021743770 hasPublicationYear "2020" @default.
• W3021743770 type Work @default.
• W3021743770 sameAs 3021743770 @default.
• W3021743770 citedByCount "10" @default.
• W3021743770 countsByYear W30217437702021 @default.
• W3021743770 countsByYear W30217437702022 @default.
• W3021743770 countsByYear W30217437702023 @default.
• W3021743770 crossrefType "journal-article" @default.
• W3021743770 hasAuthorship W3021743770A5002506738 @default.
• W3021743770 hasAuthorship W3021743770A5014684613 @default.
• W3021743770 hasAuthorship W3021743770A5015310872 @default.
• W3021743770 hasAuthorship W3021743770A5016042114 @default.
• W3021743770 hasAuthorship W3021743770A5019973671 @default.
• W3021743770 hasAuthorship W3021743770A5055673489 @default.
• W3021743770 hasAuthorship W3021743770A5057733587 @default.
• W3021743770 hasAuthorship W3021743770A5060621476 @default.
• W3021743770 hasAuthorship W3021743770A5083682224 @default.
• W3021743770 hasAuthorship W3021743770A5084231801 @default.
• W3021743770 hasAuthorship W3021743770A5085138102 @default.
• W3021743770 hasAuthorship W3021743770A5086842971 @default.
• W3021743770 hasBestOaLocation W30217437701 @default.
• W3021743770 hasConcept C126322002 @default.
• W3021743770 hasConcept C134018914 @default.
• W3021743770 hasConcept C150903083 @default.
• W3021743770 hasConcept C164027704 @default.
• W3021743770 hasConcept C165220095 @default.
• W3021743770 hasConcept C185592680 @default.
• W3021743770 hasConcept C207001950 @default.
• W3021743770 hasConcept C2776914184 @default.
• W3021743770 hasConcept C2777956040 @default.
• W3021743770 hasConcept C2779855799 @default.
• W3021743770 hasConcept C2911091166 @default.
• W3021743770 hasConcept C555293320 @default.
• W3021743770 hasConcept C71924100 @default.
• W3021743770 hasConcept C86803240 @default.

• next